Stockhead’s resident health and biotech expert Tim Boreham is putting down the pen and picking up the microphone for another instalment of The Health Kick Podcast.
In this episode, Tim chats with Dr Chris Baldwin, chief commercial officer of Exopharm (ASX:EX1)
Exopharm is a clinical-stage Australian biopharmaceutical company using exosomes to generate a new class of cell-free medicines.
The company has partnered with LEAP Technology to explore regenerative medicine and to expedite the development of exosome-based therapies.
Dr Chris recently spoke to Stockhead about how mRNA vaccines could defeat the novel coronavirus.
Click below to hear more about pioneering the exosome medicines field and Exopharm’s journey to commercialising its product.
On mobile? Click here to listen with Apple podcasts, here for Spotify or here for Google Podcasts.
Like to listen to podcasts through another app? Just search for The Health Kick Podcast with Tim Boreham and subscribe!